MiniMed Group, Inc. (MMED) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-234.6%

-$25.45

vs $18.90 price

Levered DCF

-$34.93

After debt service

Piotroski score

2 / 9

Weak

Altman Z-score

3.72

Safe zone

Rating

Overall 3 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022
P/E	-10.23×	-20.78×	-46.22×	-54.38×
P/B	0.94×	1.56×	1.51×	0×
P/S	1.09×	1.91×	2.1×	2.31×
EV / EBITDA	15.78×	48.53×	87.22×	0×
Gross margin	54.2%	56.2%	58.2%	58.3%
Operating margin	1.6%	-7.4%	-2.8%	-3.1%
Net margin	-10.7%	-9.2%	-4.5%	-4.3%
Current ratio	1.92×	1.32×	1.73×	0×
Debt / equity	0.04×	0×	0×	0×
Interest coverage	0×	0×	0×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022
Return on equity	-9.2%	-7.5%	-3.2%	0.0%
Return on invested capital	1.2%	-5.8%	-1.9%	0.0%
Return on assets	-7.1%	-6.0%	-2.7%	0.0%
Free cash flow yield	-12.4%	-1.0%	-2.1%	-3.3%
Earnings yield	-9.8%	-4.8%	-2.2%	-1.8%
Enterprise value	$3.2B	$5.2B	$5.1B	$0
Net debt / EBITDA	-0.75×	0×	-0.78×	0×
Cash conversion cycle (days)	123	109	111	0